Filing Details

Accession Number:
0001127602-23-022961
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-18 17:05:02
Reporting Period:
2023-08-16
Accepted Time:
2023-08-18 17:05:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1531048 Inari Medical Inc. NARI Surgical & Medical Instruments & Apparatus (3841) 452902923
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1806431 Andrew Hykes C/O Inari Medical, Inc.
6001 Oak Canyon
Irvine CA 92618
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-08-16 18,166 $65.31 493,642 No 4 S Direct
Common Stock Disposition 2023-08-16 8,009 $66.32 485,633 No 4 S Direct
Common Stock Disposition 2023-08-16 9,906 $67.31 475,727 No 4 S Direct
Common Stock Disposition 2023-08-16 595 $68.03 475,132 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,550 Indirect By Child 1
Common Stock 1,550 Indirect By Child 2
Common Stock 1,550 Indirect By Child 3
Common Stock 1,000 Indirect By Spouse
Footnotes
  1. Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the distribution and settlement of previously vested Restricted Stock Units (RSUs). The sale to cover transactions were irrevocably agreed to in writing by the Reporting Person prior to the distribution of the RSUs to satisfy the tax withholding obligations and do not represent a discretionary transaction by the Reporting Person.
  2. This transaction was executed in multiple trades at prices ranging from $64.88 to $65.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $65.88 to $66.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $66.88 to $67.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $67.89 to $68.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. Includes 199 shares acquired on July 31, 2023, under the Company's Employee Stock Purchase Plan.